Innovative MedTech, Inc.

OTCPK:IMTH Stock Report

Market Cap: US$11.5m

Innovative MedTech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Michael Friedman

Chief executive officer

US$306.0k

Total compensation

CEO salary percentage49.0%
CEO tenure3.8yrs
CEO ownership12.2%
Management average tenureno data
Board average tenure2.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Friedman's remuneration changed compared to Innovative MedTech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$9m

Jun 30 2024US$306kUS$150k

-US$8m

Mar 31 2024n/an/a

-US$2m

Dec 31 2023n/an/a

-US$2m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023US$306kUS$150k

-US$4m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022n/an/a

-US$20m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022US$306kUS$150k

-US$18m

Mar 31 2022n/an/a

-US$1m

Dec 31 2021n/an/a

-US$3m

Sep 30 2021n/an/a

-US$3m

Jun 30 2021n/an/a

-US$3m

Jun 30 2020US$168kUS$144k

-US$490k

Jun 30 2019US$144kUS$144k

-US$358k

Compensation vs Market: Michael's total compensation ($USD306.00K) is below average for companies of similar size in the US market ($USD649.25K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


CEO

Michael Friedman (46 yo)

3.8yrs

Tenure

US$306,000

Compensation

Mr. Michael Jordan Friedman, JD, LLM is President, Chief Executive Officer and Director of Trident Brands Incorporated from October 01, 2021. He is Chief Executive Officer, President and Chief Financial Of...


Board Members

NamePositionTenureCompensationOwnership
Michael Friedman
CEO, President22yrsUS$306.00k12.24%
$ 1.4m
Lawrence Kremer
Member of Board of Advisorno datano datano data
Harry Topalian
Member of Board of Advisorno datano datano data
Salvatore Cingari
Member of Board of Advisorno datano datano data
Joseph Ackilli
Member of Board of Advisorno datano datano data
Anthony Buono
Member of Board of Advisorno datano datano data
Roscoe Moore
Member of Scientific Advisory Board1.7yrsno datano data
Charles Everhardt
Chairman of the Board3.8yrsno data8.81%
$ 1.0m
David Webb
Member of External Advisory Board2.7yrsno datano data
Bruce McDermott
Member of External Advisory Board2.7yrsno datano data

2.7yrs

Average Tenure

80.5yo

Average Age

Experienced Board: IMTH's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 05:03
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innovative MedTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution